Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter.
Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page R5
(=TENES
Committee
Staff
Mandate of the Committee
Process of the Committee
Introduction
f~ti~;
ISSUR 1:
Issue 2:
Issue 3:
Issue 4:
References
Data Needed for Better Problem Definition
· · ~
111
TV
The Funding of Clinical Investigation
in the United States 6
Recommendations.... e ~ ~ e ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ 7
Training of the Young Clinical
Investigator ~ the United States..~. 9
Resc~Lndations 10
Resource Considerations and Necessary
Organization and Structure of
Clinical Investigation 11
Recol=endations 11
Outcome Assessment Research 15
Rscom=endations ~ . 16
17
20
Affix A: Publications Consulted 23
Affix B: Position Ears by remittee
Mama 29
v
OCR for page R6
Issue 1: m e Funding of Clinical
Investigation in the
United States
Ruth S. Hanft
Gerald D. Laubach
Mitchell T. RabRin
Issue 2: Training and Support of the
Young Clinical Investigator
in the United States
myomas c. R~rigan
David G. Nathan
~r1 C. E - k
Robert M. Rose
Barry Sherman
(Submitter by
David Martin)
Paul D. Stolley
Samuel A. Wells, Jr.
Issue 3:
Organizational Structure
of Clinical Investigation
in the Future
William N. Kelley
Elaine L. Larson
I~uis lasagna
Issue 4: me Need for Clinical
Investigators to be
Concerned with the Issues
of Outcome Assessment and
Cost-Effectiveness Analysis
John E. Wennberg
V1
30
31
36
48
50
51
54
57
59
61
63
65
69
70
75
78
81
82
